- Home
- SGLY vs SILO Comparison
SGLY vs SILO Comparison
Compare SGLY & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGLY
- SILO
- Stock Information
- Founded
- SGLY 2001
- SILO 2010
- Country
- SGLY United States
- SILO United States
- Employees
- SGLY N/A
- SILO N/A
- Industry
- SGLY
- SILO Apparel
- Sector
- SGLY
- SILO Consumer Discretionary
- Exchange
- SGLY Nasdaq
- SILO Nasdaq
- Market Cap
- SGLY 3.9M
- SILO 4.3M
- IPO Year
- SGLY 2008
- SILO N/A
- Fundamental
- Price
- SGLY $1.02
- SILO $0.63
- Analyst Decision
- SGLY
- SILO
- Analyst Count
- SGLY 0
- SILO 0
- Target Price
- SGLY N/A
- SILO N/A
- AVG Volume (30 Days)
- SGLY 52.7K
- SILO 2.2M
- Earning Date
- SGLY 08-26-2025
- SILO 08-12-2025
- Dividend Yield
- SGLY N/A
- SILO N/A
- EPS Growth
- SGLY N/A
- SILO N/A
- EPS
- SGLY N/A
- SILO N/A
- Revenue
- SGLY $2,172,036.00
- SILO $72,102.00
- Revenue This Year
- SGLY N/A
- SILO $1.86
- Revenue Next Year
- SGLY N/A
- SILO N/A
- P/E Ratio
- SGLY N/A
- SILO N/A
- Revenue Growth
- SGLY N/A
- SILO N/A
- 52 Week Low
- SGLY $0.54
- SILO $0.41
- 52 Week High
- SGLY $7.65
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- SGLY 51.57
- SILO 50.82
- Support Level
- SGLY $1.02
- SILO $0.60
- Resistance Level
- SGLY $1.16
- SILO $0.66
- Average True Range (ATR)
- SGLY 0.08
- SILO 0.04
- MACD
- SGLY -0.01
- SILO 0.02
- Stochastic Oscillator
- SGLY 50.00
- SILO 69.70
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.